Brain implant zaps seizures in real time for hard-to-treat epilepsy
Disease control
Ongoing
This study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy. The device detects abnormal brain activity and delivers small electrical pulses to stop seizures before they start. The goal i…
Phase: PHASE2 • Sponsor: NeuroPace • Aim: Disease control
Last updated May 17, 2026 06:50 UTC